Intelligent Bio Solutions (INBS) EBITDA Margin (2022 - 2026)
Intelligent Bio Solutions' EBITDA Margin came in at -321.22% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 11.30 percentage points from -332.52% a year earlier but down 70.78 percentage points from the prior quarter.
Powered by 
Analysis
Intelligent Bio Solutions (INBS) EBITDA Margin (2022 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Intelligent Bio Solutions' EBITDA Margin was -271.50%, up 38.78 percentage points from FY2025.
- EBITDA Margin carries a four-year change of +1635.61 percentage points (FY2022 to FY2026).
- Going back by fiscal year, EBITDA Margin was -310.28% in FY2025, -937.31% in FY2023 (+969.81 pp) and -1907.11% in FY2022.
- The five-year range for quarterly EBITDA Margin is -3123.32% (fiscal Q4 2022) to -230.34% (fiscal Q2 2024).
- Year-over-year, EBITDA Margin has increased for four consecutive quarters, with an average year-over-year change of +14.22 percentage points over the last seven quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q4 2023 (a gain of 2538.73 percentage points), and the weakest in fiscal Q3 2023 (a drop of 656.84 percentage points).
- Business Quant data shows INBS's EBITDA Margin at -250.44% (Q3 2026), -257.41% (Q2 2026) and -246.60% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | Intelligent Bio Solutions | 2.43 Mn | -11.04 Mn | 536,583.00 | -321.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -321.22% |
| Mar 31, 2026 | -250.44% |
| Dec 31, 2025 | -257.41% |
| Sep 30, 2025 | -246.60% |
| Jun 30, 2025 | -332.52% |
| Mar 31, 2025 | -309.84% |
| Dec 31, 2024 | -312.00% |
| Sep 30, 2024 | -284.73% |
| Mar 31, 2024 | -326.08% |
| Dec 31, 2023 | -230.34% |
| Sep 30, 2023 | -286.24% |
| Jun 30, 2023 | -584.59% |
| Mar 31, 2023 | -1,354.41% |
| Dec 31, 2022 | -485.82% |
| Jun 30, 2022 | -3,123.32% |
| Mar 31, 2022 | -697.57% |
API Access
Intelligent Bio Solutions EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();